Google Parent and Sanofi Name Diabetes Joint Venture Onduo
September 12 2016 - 2:23AM
Dow Jones News
By Inti Landauro
PARIS--French pharmaceutical group Sanofi SA is joining with
Verily Life Sciences LLC, a unit of Google parent Alphabet, to
create a joint venture called Onduo to research diabetes
treatments.
"Onduo's mission is to help people with diabetes live full,
healthy lives by developing comprehensive solutions that combine
devices, software, medicine, and professional care to enable simple
and intelligent disease management," Sanofi and Verily, which was
previously known as Google Life Science, said.
The two companies appointed Joshua Riff, who was a senior
executive at UnitedHealth Group's Optum, as the chief executive of
the new unit.
Sanofi is a leading maker of diabetes medication, as well as
many other drugs.
Onduo will combine Verily's experience in miniaturized
electronics, analytics, and consumer software development, and
Sanofi's clinical expertise and experience in providing treatment
to diabetic people.
Sanofi is seeking new diabetes treatments as revenue from its
diabetes drugs in the U.S. fell after its insulin Lantus lost
patent protection there.
Diabetes is expected to affect 592 million people world-wide by
2035, according to the International Diabetes Federation.
Write to Inti Landauro at inti.landauro@wsj.com
(END) Dow Jones Newswires
September 12, 2016 02:08 ET (06:08 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
Sanofi (NASDAQ:SNY)
Historical Stock Chart
From Apr 2024 to May 2024
Sanofi (NASDAQ:SNY)
Historical Stock Chart
From May 2023 to May 2024
